Bank of New York Mellon Corp - PROTHENA CORP PLC ownership

PROTHENA CORP PLC's ticker is PRTA and the CUSIP is G72800108. A total of 138 filers reported holding PROTHENA CORP PLC in Q2 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PROTHENA CORP PLC
ValueSharesWeighting
Q3 2023$24,095,165
-31.4%
499,382
-2.9%
0.01%
-28.6%
Q2 2023$35,111,798
+341.5%
514,233
+213.4%
0.01%
+250.0%
Q1 2023$7,953,528
-3.6%
164,092
+19.8%
0.00%0.0%
Q4 2022$8,254,056
-2.9%
136,997
-2.3%
0.00%0.0%
Q3 2022$8,501,000
+162.3%
140,192
+17.4%
0.00%
+100.0%
Q2 2022$3,241,000
-42.6%
119,364
-22.6%
0.00%0.0%
Q1 2022$5,642,000
-25.1%
154,281
+1.2%
0.00%0.0%
Q4 2021$7,531,000
-23.0%
152,460
+11.1%
0.00%
-50.0%
Q3 2021$9,779,000
+40.4%
137,287
+1.4%
0.00%
+100.0%
Q2 2021$6,963,000
+113.2%
135,455
+4.2%
0.00%0.0%
Q1 2021$3,266,000
+95.0%
130,000
-6.8%
0.00%
Q4 2020$1,675,000
+12.8%
139,522
-6.2%
0.00%
Q3 2020$1,485,000
-11.0%
148,682
-6.8%
0.00%
Q2 2020$1,668,000
-53.1%
159,549
-52.0%
0.00%
-100.0%
Q1 2020$3,557,000
-33.2%
332,440
-1.2%
0.00%0.0%
Q4 2019$5,327,000
+103.6%
336,512
+0.8%
0.00%0.0%
Q3 2019$2,617,000
-27.0%
333,829
-1.6%
0.00%0.0%
Q2 2019$3,587,000
-18.2%
339,312
-6.1%
0.00%0.0%
Q1 2019$4,384,000
+14.1%
361,488
-3.1%
0.00%0.0%
Q4 2018$3,842,000
+43.9%
373,072
+82.9%
0.00%0.0%
Q3 2018$2,669,000
-2.7%
204,002
+8.5%
0.00%0.0%
Q2 2018$2,742,000
-58.3%
188,095
+4.9%
0.00%
-50.0%
Q1 2018$6,580,000
-0.2%
179,253
+1.9%
0.00%0.0%
Q4 2017$6,592,000
-45.1%
175,848
-5.2%
0.00%
-33.3%
Q3 2017$12,010,000
+19.7%
185,420
-0.0%
0.00%0.0%
Q2 2017$10,037,000
+4.6%
185,462
+7.8%
0.00%0.0%
Q1 2017$9,594,000
+20.7%
171,970
+6.4%
0.00%
+50.0%
Q4 2016$7,947,000
-17.1%
161,573
+1.0%
0.00%
-33.3%
Q3 2016$9,591,000
+68.6%
159,944
-1.7%
0.00%
+50.0%
Q2 2016$5,687,000
-14.1%
162,670
+1.2%
0.00%0.0%
Q1 2016$6,617,000
-40.4%
160,753
-1.3%
0.00%
-33.3%
Q4 2015$11,097,000
+47.6%
162,937
-1.7%
0.00%
+50.0%
Q3 2015$7,518,000
-26.0%
165,804
-14.0%
0.00%
-33.3%
Q2 2015$10,160,000
+75.5%
192,900
+27.1%
0.00%
+50.0%
Q1 2015$5,789,000
+100.0%
151,785
+8.9%
0.00%
+100.0%
Q4 2014$2,895,000
+5.1%
139,438
+12.2%
0.00%0.0%
Q3 2014$2,754,000
-37.3%
124,298
-36.2%
0.00%0.0%
Q2 2014$4,394,000
+33.6%
194,882
+127.0%
0.00%0.0%
Q1 2014$3,289,000
+72.3%
85,837
+19.3%
0.00%0.0%
Q4 2013$1,909,000
+75.1%
71,971
+33.6%
0.00%
Q3 2013$1,090,000
+72.7%
53,867
+10.3%
0.00%
Q2 2013$631,00048,8350.00%
Other shareholders
PROTHENA CORP PLC shareholders Q2 2019
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 11,584,280$697,952,87021.24%
Prosight Management, LP 330,000$19,882,50010.84%
First Light Asset Management, LLC 1,535,599$92,519,8408.59%
Palo Alto Investors LP 1,658,577$99,929,2648.52%
Finepoint Capital LP 322,900$19,4556.29%
Birchview Capital, LP 127,195$7,6635.41%
Avidity Partners Management LP 2,953,000$177,918,2503.85%
DCF Advisers, LLC 74,100$4,464,5253.02%
PFM Health Sciences, LP 875,464$52,746,7061.89%
SECTORAL ASSET MANAGEMENT INC 115,200$6,940,8001.34%
View complete list of PROTHENA CORP PLC shareholders